How to deal with nosebleeds while taking trametinib?

Nosebleeds are uncommon but may occur in some patients while taking Trametinib. This situation is often related to the effect of the drug on vessel wall stability, coagulation function, or mucosal tolerance. Once epistaxis occurs, patients should pay attention, not only to rule out serious problems, but also to adopt scientific and reasonable responses.

When nose bleeding is detected, physical hemostasis should be carried out immediately. The patient can sit in a sitting position with the head tilted slightly forward to prevent blood from flowing back into the pharynx and causing discomfort. Then pinch the cartilage of the nose with your thumb and index finger and continue to compress for 5 to 10 minutes. At the same time, you can apply a cold towel on the bridge of the nose or the back of the neck to help shrink blood vessels and reduce bleeding. If the bleeding continues for more than 20 minutes and cannot be stopped, it is recommended to seek medical attention immediately.

You need to be alert to drug-related bleeding tendencies. Trametinib itself, as a MEK inhibitor, may cause certain damage to the skin and mucous membranes, leading to rupture of nasal capillaries. In addition, if patients take other anticoagulants, aspirin-like drugs, or other targeted drugs at the same time, the risk of bleeding may be further increased. Therefore, all medications being used should be described to your doctor so that you can assess whether dosage or combination regimens need to be adjusted.

In order to prevent further bleeding, patients should keep their nasal cavity moist in daily life and avoid picking or blowing their nose vigorously. Use a saline nasal spray or room humidifier to reduce nasal dryness while avoiding heat, allergens, or dust irritation. If epistaxis occurs repeatedly or is accompanied by other abnormal bleeding (such as gum bleeding, skin ecchymosis, etc.), routine blood tests and coagulation function tests should be performed as soon as possible to determine whether there is bone marrow suppression or coagulation abnormalities caused by drugs, and treatment strategies should be adjusted according to the doctor's recommendations.

Reference materials:https://go.drugbank.com/drugs/DB08911